FDA Drugs recall ·

Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL)… recall

Recall number
D-0714-2026
Date
(initiated June 10, 2026)
Company / brand
McKesson
6555 State Highway 161, Irving, TX, United States
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Units affected
74 units
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH, Schiffgraben 23, 38690 Goslar, Germany; Distributed by: Hikma, Berkeley Heights, NJ 07922. NDC: 0143-9341-01

Why was it recalled?

Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot #: CB0046, Exp. Date 06/2027

Distribution

Nationwide within the United States

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0714-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.